Amplia Therapeutics Limited
INNMF
$0.12
-$0.005-4.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.18M | -1.22M | -942.80K | -927.20K | -1.11M |
| Total Depreciation and Amortization | 13.30K | 13.80K | 14.50K | 14.30K | 14.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -459.20K | -477.00K | 535.50K | 526.70K | 836.10K |
| Change in Net Operating Assets | -167.50K | -174.00K | -- | -- | -261.70K |
| Cash from Operations | -1.79M | -1.86M | -392.70K | -386.30K | -521.00K |
| Capital Expenditure | -500.00 | -500.00 | -100.00 | -100.00 | -700.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -500.00 | -500.00 | -100.00 | -100.00 | -700.00 |
| Total Debt Issued | -- | -- | -- | -- | 733.50K |
| Total Debt Repaid | -20.90K | -20.90K | -754.10K | -754.10K | -1.07M |
| Issuance of Common Stock | 6.51M | 6.51M | 2.13M | 2.13M | 100.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -508.00K | -508.00K | -197.50K | -197.50K | -7.20K |
| Cash from Financing | 3.75M | 3.90M | 792.30K | 779.20K | -226.00K |
| Foreign Exchange rate Adjustments | 20.40K | 21.20K | -6.40K | -6.30K | 900.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.98M | 2.05M | 393.00K | 386.50K | -746.90K |